What are the side effects of magnesium sulfate in a pregnant woman with preeclampsia?

Side Effects of Magnesium Sulfate in Pregnant Women with Preeclampsia

Magnesium sulfate causes common minor side effects including flushing, sweating, and injection site reactions, but serious toxicity—manifesting as respiratory depression, cardiac depression, and circulatory collapse—occurs when serum levels exceed therapeutic range and is associated with increased maternal and perinatal mortality. 1

Common Side Effects

Minor Maternal Effects

• Flushing and sweating occur frequently as vasodilatory effects 1
• Injection site complications are extremely common with intramuscular administration:
  • Pain at injection site: 91-95% of patients 2
  • Inflammation: 40-62% of patients 2
  • Bleeding or bruising: 14-25% of patients 2
• Hypotension may develop, particularly with rapid IV administration 1

Obstetric Effects

• Increased length of labor has been documented 3
• Increased cesarean delivery rate compared to no treatment 3
• Increased postpartum bleeding 3
• Decreased neuromuscular transmission affecting muscle function 3

Serious Adverse Effects and Toxicity

Signs of Magnesium Intoxication

Magnesium toxicity represents a medical emergency with progressive neurological and cardiorespiratory depression. 1 The clinical progression includes:

• Depressed or absent deep tendon reflexes (earliest sign) 4
• Respiratory depression and bradypnea 5, 1
• Flaccid paralysis 1
• Hypothermia 1
• Cardiac depression progressing to circulatory collapse 1
• Respiratory paralysis (terminal event) 1

Mortality and Morbidity from Toxicity

• Maternal death from overdose has been reported 3
• In one study of magnesium-intoxicated women (serum levels 12.36 ± 3.54 mg/dL), 3 maternal deaths and 3 cases of major maternal morbidity occurred compared to zero in non-intoxicated controls 6
• Magnesium intoxication is significantly associated with perinatal deaths and low Apgar scores at 1 and 5 minutes 6

Respiratory Complications

• Respiratory depression occurs in approximately 2% of treated patients (RR 2.06; 95% CI 1.33-3.18) 7
• This represents the most common serious complication requiring intervention 7

Metabolic and Electrolyte Effects

• Hypocalcemia with signs of tetany secondary to magnesium sulfate therapy has been reported 1
• This occurs because magnesium antagonizes calcium at the neuromuscular junction 1

Drug Interactions

Myocardial depression may follow combination of calcium channel blockers (particularly nifedipine) with intravenous magnesium 8

• This interaction can cause severe cardiovascular compromise 8
• Caution is required when using both medications concurrently 8

Fetal and Neonatal Effects

With Prolonged Use

Continuous maternal administration of magnesium sulfate in pregnancy beyond 5 to 7 days can cause fetal abnormalities 1

• This is an FDA-labeled warning requiring strict adherence to duration limits 1

With Toxicity

• Perinatal mortality is significantly increased when maternal magnesium intoxication occurs 6
• Low Apgar scores at both 1 and 5 minutes are associated with maternal toxicity 6

Monitoring to Prevent Toxicity

Clinical monitoring is sufficient and preferred over serum magnesium levels for routine use. 9 The ISSHP guidelines emphasize that appropriate monitoring must include: 4

• Respiratory rate (should remain >12-16 breaths/minute)
• Deep tendon reflexes (patellar reflex must be present)
• Urine output (maintain >25-30 mL/hour)
• Oxygen saturation monitoring 5

Serum magnesium levels are only needed when toxicity is suspected (absent reflexes, bradypnea, respiratory arrest) or in the presence of renal impairment 5, 9

Risk Mitigation Strategies

Dosing Precautions

• Maximum rate of IV injection should not exceed 150 mg/minute (1.5 mL of 10% concentration) except in severe eclampsia with active seizures 1
• Total daily dose should not exceed 30-40 grams 1
• In severe renal insufficiency, maximum dosage is 20 grams per 48 hours with mandatory frequent serum concentration monitoring 1

Duration Limits

• Treatment should not normally exceed 24 hours postpartum 4, 9
• Never continue beyond 5-7 days due to risk of fetal abnormalities 1

Fluid Management

Total fluid intake must be limited to 60-80 mL/hour to avoid pulmonary edema, as preeclamptic women have capillary leak 4

Common Pitfalls to Avoid

• Do not rely solely on serum magnesium levels—clinical monitoring of reflexes, respiration, and urine output is more practical and equally effective 9
• Do not combine with calcium channel blockers without extreme caution due to risk of severe myocardial depression 8
• Do not exceed recommended duration of therapy, particularly the 5-7 day maximum for continuous use 1
• Do not use in patients with severe renal insufficiency without dose adjustment and enhanced monitoring 1